« Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: Myth or Reality? ». Canadian Diabetes & Endocrinology Today, vol. 3, nᵒ 1, mai 2025, p. 17–22, https://doi.org/10.58931/cdet.2025.3137.